Search
Patexia Research
Case number 2:25-cv-14648

GENENTECH, INC. et al v. SHANGHAI HENLIUS BIOTECH, INC. et al > Summary

Court Case Number 2:25-cv-14648

Filing Date Aug 14, 2025

Court New Jersey District Court

Status Unknown

JudgesClaire C. Cecchi

Plaintiff

2

Genentech, Inc

Roche

Defendant

2

Organon International

Shanghai Henlius Biotech Inc.

Related Patents

Doc No Title Issue date
12173080 Prevention of disulfide bond reduction during recombinant production of polypeptides Dec 24, 2024
12145997 Prevention of disulfide bond reduction during recombinant production of polypeptides Nov 19, 2024
12128103 Adjuvant treatment of HER2-positive breast cancer Oct 29, 2024
12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof Oct 8, 2024
12103975 Production of proteins in glutamine-free cell culture media Oct 1, 2024
11992529 Adjuvant treatment of HER2-positive breast cancer May 28, 2024
11655305 Treatment of metastatic breast cancer May 23, 2023
11638756 Adjuvant treatment of HER2-positive breast cancer May 2, 2023
11597776 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof Mar 7, 2023
11414498 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof Aug 16, 2022
11077189 Adjuvant treatment of HER2-positive breast cancer Aug 3, 2021
11078294 Prevention of disulfide bond reduction during recombinant production of polypeptides Aug 3, 2021
10808037 Prevention of disulfide bond reduction during recombinant production of polypeptides Oct 20, 2020
10689457 Treatment of metastatic breast cancer Jun 23, 2020
10676710 Cell culture compositions with antioxidants and methods for polypeptide production Jun 9, 2020
10662237 Method to improve virus filtration capacity May 26, 2020
09969811 Pertuzumab variants and evaluation thereof May 15, 2018
09815904 Pertuzumab variants and evaluation thereof Nov 14, 2017
09181346 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof Nov 10, 2015
08652474 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof Feb 18, 2014
08404234 Fixed dosing of HER antibodies Mar 26, 2013
07862817 Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies Jan 4, 2011
07449184 Fixed dosing of HER antibodies Nov 11, 2008
Menu